India Glycols

Which are the latest news on India Glycols?

Why is India Glycols Ltd falling/rising?

As of 05-Sep, India Glycols Ltd's stock price is rising to Rs. 266.00, up 4.99%, supported by strong performance metrics and positive financial results. The stock has outperformed its sector and benchmarks, showing significant returns and a high dividend yield, making it an attractive investment despite reduced investor participation.

As of 05-Sep, India Glycols Ltd's stock price is rising, currently at Rs. 266.00, reflecting an increase of Rs. 12.65 or 4.99%. This upward movement is supported by several positive factors. The stock has outperformed the sector by 4.72% today and has been on a gaining streak for the last three days, accumulating a total return of 10.65% during this period. Additionally, the stock opened with a gain of 4.99% and reached a new 52-week high of Rs. 266.<BR><BR>In terms of performance relative to benchmarks, India Glycols has shown strong returns over various periods, including a 20.86% increase year-to-date and a remarkable 223.28% rise over the past three years, significantly outperforming the Sensex. The company has also reported positive financial results for the last six consecutive quarters, with a return on capital employed (ROCE) of 11.79%, the highest in its half-year results, and a low debt-equity ratio of 0.58.<BR><BR>Moreover, the stock is trading at a discount compared to its peers, with a high dividend yield of 4.78% at the current price, making it an attractive investment. Despite a decline in investor participation, as indicated by a significant drop in delivery volume, the overall financial health and consistent returns of India Glycols Ltd contribute to the rising stock price.

Should I buy, sell or hold India Glycols Ltd?

Who are in the management team of India Glycols?

The management team of India Glycols includes U S Bhartia (Chairman), Jayshree Bhartia (Non-Executive Director), Pragya Bhartia Barwale, Sudhir Agarwal (both Executive Directors), and several Independent Non-Executive Directors: Pradip Kumar Khaitan, Jitender Balakrishnan, Ravi Jhunjhunwala, Jagmohan N Kejriwal, Sajeve Deora, and Shukla Wassan. They guide the company's strategic direction and operations.

The management team of India Glycols includes the following individuals:<BR><BR>1. **U S Bhartia** - Chairman / Executive Director<BR>2. **Jayshree Bhartia** - Non-Executive Director<BR>3. **Pragya Bhartia Barwale** - Executive Director<BR>4. **Sudhir Agarwal** - Executive Director<BR>5. **Pradip Kumar Khaitan** - Independent Non-Executive Director<BR>6. **Jitender Balakrishnan** - Independent Non-Executive Director<BR>7. **Ravi Jhunjhunwala** - Independent Non-Executive Director<BR>8. **Jagmohan N Kejriwal** - Independent Non-Executive Director<BR>9. **Sajeve Deora** - Independent Non-Executive Director<BR>10. **Shukla Wassan** - Independent Non-Executive Director<BR><BR>This team plays a crucial role in guiding the company's strategic direction and operations.

What does India Glycols do?

India Glycols Ltd is a small-cap company in the commodity chemicals industry, serving sectors like textiles and pharmaceuticals, with a market cap of INR 7,859 Cr and a net profit of 97 Cr for June 2026. Key metrics include a P/E of 24.00 and a dividend yield of 1.03%.

Overview:<BR>India Glycols Ltd is a small-cap company operating in the commodity chemicals industry, providing products to various sectors including textiles, agrochemicals, and pharmaceuticals.<BR><BR>History:<BR>India Glycols Limited was incorporated as UP Glycols Limited and changed its name in September 1986. The latest quarterly results reported net sales and profit for June 2026.<BR><BR>Financial Snapshot:<BR>Net Sales: 1,130 Cr (Quarterly Results - Jun 2026) <BR>Net Profit: 97 Cr (Quarterly Results - Jun 2026) <BR>Market Cap: INR 7,859 Cr (Small Cap)<BR><BR>Key Metrics:<BR>P/E: 24.00 <BR>Industry P/E: 43 <BR>Dividend Yield: 1.03% <BR>Debt Equity: 0.56 <BR>Return on Equity: 10.00% <BR>Price to Book: 2.69 <BR><BR>Contact Details:<BR>Address: A-1 Industrial Area, Bazpur Road Kashipur Udham Singh Nagar UTT : 244713 <BR>Tel: 91-05947-269000/269500/275320 <BR>Email: compliance.officer@indiaglycols.com <BR>Website: http://www.indiaglycols.com

Who are the peers of the India Glycols?

Peers of India Glycols include Tata Chemicals, Tanfac Inds., Gujarat Alkalies, GHCL, Grauer & Weil, Chemplast Sanmar, J.G.Chemicals, Fischer Medical, and Thirumalai Chem. India Glycols has the highest 1-year return among its peers at 41.38%, while several peers, including Fischer Medical, have negative returns.

Peers: The peers of India Glycols are Tata Chemicals, Tanfac Inds., Gujarat Alkalies, GHCL, Grauer & Weil, Chemplast Sanmar, J.G.Chemicals, Fischer Medical, and Thirumalai Chem.<BR><BR>Quality Snapshot: Excellent management risk is observed at GHCL and Chemplast Sanmar, while Average management risk is found at Tata Chemicals, India Glycols, Tanfac Inds., Gujarat Alkalies, Grauer & Weil, J.G.Chemicals, Fischer Medical, and Thirumalai Chem. Growth is rated as Good for J.G.Chemicals and Excellent for Fischer Medical, while Below Average growth is noted for Tata Chemicals, India Glycols, Tanfac Inds., Gujarat Alkalies, GHCL, Grauer & Weil, Chemplast Sanmar, and Thirumalai Chem. Capital Structure is rated as Excellent for Tanfac Inds., Gujarat Alkalies, GHCL, Grauer & Weil, and J.G.Chemicals, while Below Average is seen at India Glycols and Chemplast Sanmar.<BR><BR>Return Snapshot: The peer with the highest 1-year return is India Glycols at 41.38%, while the lowest is Fischer Medical at -66.23%, indicating that India Glycols significantly outperforms its peers. Additionally, GHCL, Chemplast Sanmar, Fischer Medical, and Thirumalai Chem. all have negative six-month returns.

How big is India Glycols?

As of 31st August, India Glycols Ltd has a market capitalization of 7,859.00 Cr, with recent net sales of 4,301.34 Cr and a net profit of 316.34 Cr. The company has shareholder's funds of 2,932.78 Cr and total assets of 6,522.95 Cr.

As of 31st August, India Glycols Ltd has a market capitalization of 7,859.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest four quarters, India Glycols reported Net Sales of 4,301.34 Cr and a Net Profit of 316.34 Cr.<BR><BR>For the reporting period of March 2026, the company has Shareholder's Funds amounting to 2,932.78 Cr and Total Assets of 6,522.95 Cr.

When is the next results date for India Glycols Ltd?

The next results date for India Glycols Ltd is 12 August 2026.

The next results date for India Glycols Ltd is scheduled for 12 August 2026.

Are India Glycols Ltd latest results good or bad?

India Glycols Ltd's latest Q4 FY26 results show strong profitability with a net profit increase of 28.58% quarter-on-quarter, but a concerning 11.43% decline in net sales compared to the previous quarter. Overall, the results are good in terms of profit but mixed due to the revenue drop.

India Glycols Ltd's latest results for Q4 FY26 present a mixed picture. On one hand, the company achieved a consolidated net profit of ₹86.88 crores, marking a significant 28.58% increase quarter-on-quarter and a remarkable 35.71% growth year-on-year. This reflects strong profitability momentum and operational efficiency.<BR><BR>However, net sales decreased by 11.43% compared to the previous quarter, totaling ₹976.35 crores, although there was a year-on-year increase of 13.11%. This sequential decline in revenue raises some concerns about demand sustainability, especially given the typical seasonal patterns in the chemicals industry.<BR><BR>The operating margin also showed positive signs, reaching 17.05%, which is the highest in several quarters, indicating effective cost management and a focus on higher-margin products. The profit after tax (PAT) margin improved to 8.90%, further underscoring the company's ability to enhance profitability despite revenue pressures.<BR><BR>In summary, while the profit figures are strong and indicate effective operational management, the decline in sales could be a point of concern. Overall, the results can be seen as good in terms of profitability but mixed due to the revenue drop.

Has India Glycols Ltd declared dividend?

Yes, India Glycols Ltd has declared a dividend of 150%, amounting to ₹5 per share, with an ex-date of March 23, 2026. The company has demonstrated strong total returns across various periods, with a notable 306.65% total return over the last 5 years.

India Glycols Ltd has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 150%<BR>- Amount per share: 5<BR>- Ex-date: 23 Mar 26<BR><BR>Dividend Yield: 0.54%.<BR><BR>Total Returns by Period:<BR>In the last 3 months, the price return was -15.73%, the dividend return was 0.72%, resulting in a total return of -15.01%.<BR><BR>Over the past 6 months, the price return was 3.69%, the dividend return was 1.43%, leading to a total return of 5.12%.<BR><BR>In the 1-year period, the price return was 57.02%, with a dividend return of 2.29%, culminating in a total return of 59.31%.<BR><BR>For the 2-year period, the price return was 123.49%, the dividend return was 5.42%, resulting in a total return of 128.91%.<BR><BR>In the last 3 years, the price return was 200.09%, with a dividend return of 9.19%, leading to a total return of 209.28%.<BR><BR>Over the past 4 years, the price return was 99.42%, the dividend return was 6.71%, resulting in a total return of 106.13%.<BR><BR>In the 5-year period, the price return was 287.34%, with a dividend return of 19.31%, culminating in a total return of 306.65%.<BR><BR>Overall, India Glycols Ltd has declared a significant dividend and has shown strong total returns over various periods, indicating a positive performance trend for the company.

How has been the historical performance of India Glycols?

India Glycols has shown significant growth in net sales and profits, with net sales increasing from 2,316.99 Cr in Mar'21 to 3,768.26 Cr in Mar'25, and profit after tax rising from 129.67 Cr to 184.52 Cr in the same period, despite rising raw material costs. The company's operating profit margin improved to 13.56% in Mar'25, reflecting its strong financial performance.

Answer:<BR>The historical performance of India Glycols shows a significant upward trend in net sales and profit over the years, with the latest figures indicating a robust growth trajectory.<BR><BR>Breakdown:<BR>India Glycols has demonstrated a consistent increase in net sales, rising from 2,316.99 Cr in Mar'21 to 3,768.26 Cr in Mar'25. This growth is accompanied by a rise in total operating income, which reached 3,768.26 Cr in Mar'25, up from 2,650.86 Cr in Mar'23. The company's operating profit (PBDIT) also improved, reaching 525.49 Cr in Mar'25, compared to 319.42 Cr in Mar'23. Profit before tax increased to 245.92 Cr in Mar'25 from 153.63 Cr in Mar'23, while profit after tax rose to 184.52 Cr from 129.67 Cr in the same period. Despite fluctuations in expenses, including a notable increase in raw material costs, the operating profit margin improved to 13.56% in Mar'25 from 11.15% in Mar'23. The total assets of the company grew to 6,176.10 Cr in Mar'25, up from 4,858.33 Cr in Mar'23, while total liabilities also increased to 6,176.10 Cr from 4,858.33 Cr. Cash flow from operating activities was strong at 362.00 Cr in Mar'25, although the company faced a net cash outflow of 20.00 Cr. Overall, India Glycols has shown resilience and growth in its financial performance over the years.

Is India Glycols technically bullish or bearish?

As of 9 October 2025, the trend has shifted to bullish with moderate strength, supported by bullish daily moving averages and positive Bollinger Bands, although caution is advised due to mildly bearish weekly MACD and KST indicators.

As of 9 October 2025, the technical trend has changed from mildly bullish to bullish. The current stance is bullish with moderate strength. Key indicators supporting this include the daily moving averages being bullish and both the weekly and monthly Bollinger Bands indicating bullish momentum. However, the weekly MACD and KST are mildly bearish, suggesting some caution. The overall performance metrics show strong returns compared to the Sensex, particularly over longer time frames, reinforcing the bullish outlook.

Is India Glycols overvalued or undervalued?

As of August 8, 2025, India Glycols is considered overvalued with a PE ratio of 22.10, despite outperforming the Sensex with a 34.57% year-to-date return, as it has moved from a fair to an expensive valuation grade compared to its peers.

As of 8 August 2025, India Glycols has moved from a fair to an expensive valuation grade. The company is currently considered overvalued based on its key financial ratios. The PE ratio stands at 22.10, while the Price to Book Value is 2.39, and the EV to EBITDA is 13.46. These ratios indicate a premium valuation compared to its peers.<BR><BR>In comparison to its industry peers, India Glycols' PE ratio is significantly lower than Solar Industries at 103.57 and Gujarat Fluoroch at 61.32, both categorized as very expensive. However, it is higher than Godrej Industries, which is rated attractive with a PE of 37.72. The company's recent stock performance has outpaced the Sensex, with a year-to-date return of 34.57% compared to the Sensex's 2.20%, but this does not alter the overall assessment of its current valuation.

Who are the top shareholders of the India Glycols?

The top shareholder of India Glycols is Kashipur Holdings Limited, owning 50.35%. Other notable shareholders include 50 Foreign Institutional Investors with 2.25%, mutual funds with 0.12%, and individual investors holding 28.68%, with Puneet Bhatia as the largest public shareholder at 1.92%.

The top shareholders of India Glycols include Kashipur Holdings Limited, which holds the largest share at 50.35%. The company is primarily owned by its promoters, with no pledged promoter holdings reported. Additionally, there are 50 Foreign Institutional Investors (FIIs) collectively holding 2.25% of the shares, and mutual funds are represented by 8 schemes with a total holding of 0.12%. The highest public shareholder is Puneet Bhatia, who owns 1.92%. Individual investors collectively hold 28.68% of the company's shares.